Land: Kanada
Språk: engelska
Källa: Health Canada
HISTIDINE; L-PROLINE; SERINE; TAURINE; L-TYROSINE; GLYCINE; L-ISOLEUCINE; L-LEUCINE; L-LYSINE (L-LYSINE ACETATE); METHIONINE; L-PHENYLALANINE; L-THREONINE; TRYPTOPHAN; L-VALINE; L-ALANINE; L-ARGININE; L-ASPARTIC ACID; GLUTAMIC ACID
HOSPIRA HEALTHCARE ULC
B05BA01
AMINO ACIDS
220MG; 570MG; 347MG; 50MG; 44MG; 270MG; 534MG; 831MG; 475MG; 125MG; 300MG; 360MG; 125MG; 452MG; 490MG; 861MG; 370MG; 576MG
SOLUTION
HISTIDINE 220MG; L-PROLINE 570MG; SERINE 347MG; TAURINE 50MG; L-TYROSINE 44MG; GLYCINE 270MG; L-ISOLEUCINE 534MG; L-LEUCINE 831MG; L-LYSINE (L-LYSINE ACETATE) 475MG; METHIONINE 125MG; L-PHENYLALANINE 300MG; L-THREONINE 360MG; TRYPTOPHAN 125MG; L-VALINE 452MG; L-ALANINE 490MG; L-ARGININE 861MG; L-ASPARTIC ACID 370MG; GLUTAMIC ACID 576MG
INTRAVENOUS
250ML/500ML
Ethical
CALORIC AGENTS
Active ingredient group (AIG) number: 1850892001; AHFS:
CANCELLED POST MARKET
2016-07-29
PRESCRIBING INFORMATION AMINOSYN7-PF 7% AMINOSYN7-PF 10% (amino acids for injection 7% and 10% - pediatric formula) SULFITE-FREE NUTRITIVE SUPPLEMENT FOR INTRAVENOUS INFUSION Hospira Healthcare Corporation DATE OF PREPARATION: 1111 Dr. Frederik-Philips OCTOBER 26, 2009 St-Laurent, Quebec H4M 2X6 CONTROL #131561 _PRESCRIBING INFORMATION; Aminosyn®-PF 7% & 10% _ _Page 2 of 12 _ PRESCRIBING INFORMATION AMINOSYN 7 -PF 7% AMINOSYN 7 -PF 10% (amino acids for injection 7% and 10% - pediatric formula) Sulfite-Free THERAPEUTIC OR PHARMACOLOGIC CLASSIFICATION Nutritive Supplement for Intravenous Infusion ACTIONS AND CLINICAL PHARMACOLOGY Total parenteral nutrition consists of appropriate amino acids, electrolytes, trace metals, vitamins and an energy source; this may be accomplished in children by administering AMINOSYN 7 -PF 7% and 10% (amino acids for injection 7% and 10% - pediatric formula), Sulfite-Free plus electrolytes, concentrated dextrose or fat emulsion, vitamins and trace metals. Clinical studies in infants who required TPN therapy showed that infusion of AMINOSYN 7 -PF resulted in plasma amino acid concentrations approximating those of normal breast or formula fed infants. In addition, weight gains, nitrogen balance, and serum protein concentrations were consistent with an improving nutritional status. AMINOSYN 7 -PF contains a mixture of essential and nonessential amino acids as well as taurine. The amino acid composition has been specifically formulated to provide a well-tolerated nitrogen source for nutritional support and therapy for infants and young children. When administered in conjunction with a cysteine hydrochloride additive, AMINOSYN 7 -PF results in plasma amino acid concentrations approximating a profile consistent with that of a breastfed infant. AMINOSYN 7 -PF 7% and 10% provide amino acids to promote protein synthesis and wound healing, and to reduce the rate of endogenous protein catabolism. AMINOSYN 7 -PF can be given by central venous infusion in combination with concentrated dextrose, cys Läs hela dokumentet